Emilya Shtivelman

Title: Emilya Shtivelman: Innovator in Cancer Research

Introduction

Emilya Shtivelman is a prominent inventor based in Belmont, California. She has made significant contributions to the field of cancer research, particularly in the study of metastasis. Her innovative work has the potential to advance therapeutic strategies for treating metastatic cancer.

Latest Patents

Emilya holds a patent for a "Small animal metastasis model." This invention provides a method for initiating metastasis of human tumor cells under experimental conditions. The model utilizes immunocompromised non-human mammals with viable, xenogeneic organs or tissues as hosts for human tumor cells. The cells are introduced into the chimeric animal after the solid tissue is implanted, allowing them to grow and metastasize as they would in situ. This system enables the evaluation of therapeutic regimens to determine their efficacy against metastatic processes.

Career Highlights

Emilya Shtivelman is associated with Systemix, Inc., where she continues to push the boundaries of cancer research. Her work is characterized by a commitment to developing innovative solutions that can lead to improved patient outcomes.

Collaborations

Emilya collaborates with notable colleagues, including Reiko Namikawa and Seishi Kyoizumi. Their combined expertise enhances the research efforts at Systemix, Inc. and contributes to the advancement of cancer therapies.

Conclusion

Emilya Shtivelman's contributions to cancer research through her innovative patent and collaborative efforts highlight her role as a key figure in the scientific community. Her work continues to inspire advancements in the understanding and treatment of metastatic cancer.